X4 Pharmaceuticals, Inc.

NasdaqCM:XFOR Stock Report

Market Cap: US$103.6m

X4 Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of XFOR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders8,731,1515.12%
VC/PE Firms31,902,57718.7%
General Public50,294,52729.5%
Institutions79,618,21446.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.92%
Bain Capital Life Sciences Investors, LLC
16,915,784US$10.3m0%1.29%
8.79%
New Enterprise Associates, Inc.
14,986,793US$9.1m0%0.53%
6.57%
BlackRock, Inc.
11,210,671US$6.8m5.01%no data
4.95%
The Vanguard Group, Inc.
8,440,730US$5.1m1.82%no data
4.91%
Acorn Bioventures
8,374,789US$5.1m0%8.75%
4.18%
OrbiMed Advisors LLC
7,133,515US$4.3m0%0.07%
3.73%
Anders Hove
6,367,131US$3.9m0%no data
2.72%
Kingdon Capital Management, L.L.C.
4,638,683US$2.8m0.32%0.51%
2.51%
Adage Capital Management, L.P.
4,276,315US$2.6m0%0.01%
2.08%
Perceptive Advisors LLC
3,545,454US$2.2m0%0.06%
2.02%
Geode Capital Management, LLC
3,447,512US$2.1m-1.94%no data
1.8%
AXA Investment Managers S.A.
3,076,941US$1.9m0.03%no data
1.73%
State Street Global Advisors, Inc.
2,952,895US$1.8m6.84%no data
1.49%
Ensign Peak Advisors, Inc.
2,546,458US$1.5m0%no data
1.45%
Medical Strategy GmbH, Asset Management Arm
2,477,357US$1.5m0%0.11%
1.13%
Schonfeld Strategic Advisors LLC
1,920,800US$1.2m51.3%0.01%
0.94%
Pale Fire Capital SE
1,602,792US$973.4k805%0.2%
0.91%
UBS O'Connor LLC
1,549,358US$940.9k33.5%0.1%
0.77%
Northern Trust Global Investments
1,319,599US$801.4k25%no data
0.76%
Sio Capital Management, LLC
1,303,508US$791.6k-47.9%0.46%
0.58%
Paula Ragan
993,919US$603.6k29.9%no data
0.48%
Parkman Healthcare Partners LLC
818,727US$497.2k1.5%0.08%
0.42%
AQR Capital Management, LLC
714,565US$434.0k68.9%no data
0.37%
Point72 Asset Management, L.P.
625,052US$379.6k15.1%no data
0.3%
GSA Capital Partners LLP
507,694US$308.3k0%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 04:50
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

X4 Pharmaceuticals, Inc. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Kalpit PatelB. Riley Securities, Inc.
Leah Rush CannBrookline Capital Markets